Covishield supply: SII asks foreign countries to be patient

Serum Institute of India (SII) chief executive officer Adar Poonawalla on Sunday urged governments of other countries to be patient with regards to supplies of the Oxford-AstraZeneca Covishield vaccine as the vaccine maker had been urged to prioritise Indian requirements first. Mr. Poonawalla further said that the SII was doing its utmost to “balance the needs of the rest of the world” with the massive demand from the country.